Navigate all the latest information in lymphoma and CLL, arranged by experts and health care professionals. Listed below are recently added expert opinions.
Update on CLL induction therapy
An interview with Astrid Pavlovsky, Fundaleu CHP, Buenos Aires, AR, on the first-line treatment of chronic lymphocytic leukemia (CLL).
The effect of COVID-19 on the management of patients with lymphoma
A summary of recommendations for patients with lymphoma during the COVID-19 pandemic provided by Executive Steering Committee Member...
Educational theme | PET as a prognostic tool in lymphoma
This month, the Lymphoma Hub will be concentrating on the value of PET as a prognostic tool in lymphoma. This introductory article will touch...
Third-generation CAR-CD30 T-cell therapy for CD30-positive lymphomas
Preclinical advances of a third-generation, anti-CD30 CAR T-cell therapy were presented by Biagio De Angelis, Bambino Gesù...
New prognostic model for survival in patients with R/R DLBCL
Summary of the new prognostic model for survival presented at ASH 2019 in patients with R/R DLBCL. The study aimed to evaluate clinical...
Results from the phase II ZUMA-2 trial: CAR T therapy for MCL
During the 61st ASH Meeting & Exposition, Michael Wang presented the interim results from the ZUMA-2 trial investigating the efficacy and...
ASH 2019 | Practice-changing abstracts in lymphoma and CLL
Did you miss ASH 2019? The Lymphoma Hub has developed a downloadable resource, which provides information on the practice-changing abstracts...
Has the implementation of CAR T in the real-world happened as expected?
Claudia Rössig explains that she expected CAR T therapy to be available to patients who need it, and that expectation was met to...
Biagio De Angelis
Chiara De Philippis
Marie José Kersten